Inquiry
Form loading...

Hongjitang Pharmaceutical (Shanghe) Plant Updating Project Supposed To Be Completed At The End of 2024

2024-04-22 19:00:40

Since its establishment in 1907, Hongjitang Pharmaceutical has been a witness, inheritor, and promoter of the traditional Chinese medicine (TCM) industry, carrying the historical mission of optimizing, strengthening, and enlarging the TCM industry.

The Hongjitang Pharmaceutical Shanghe Project takes the "Research and Industrialization of Artificial Musk," which won the first prize in the National Science and Technology Progress Award, as the driving force for corporate development.

Hongjitang Pharmaceutical (Shanghe) Plant Updating Project Supposed To Be Completed At The End of 2024 (1)ikx

It aims to shape an innovative regional lighthouse-type intelligent factory, setting a new benchmark. Musk, listed as a superior item in the "Shennong Ben Cao Jing," faced increasing scarcity due to the unregulated hunting of musk deer over the years. 

Hongjitang Pharmaceutical (Shanghe) Plant Updating Project Supposed To Be Completed At The End of 2024 (6)rhr

After the government classified musk as a first-level key protected wild animal, musk became even scarcer, making it challenging to formulate many valuable Chinese patent medicines.

In the 1970s, the country identified the research on substituting natural musk as a crucial focus and successfully achieved it. The "Research and Industrialization of Artificial Musk project, in which Hongjitang Pharmaceutical participated, received the first prize in the National Science and Technology Progress Award in 2015. 

The successful development of artificial musk and l-muscone allowed the continuation of numerous classic Chinese medicine formulas. Artificial musk was approved as a Class I new drug, filling the domestic gap and pioneering the artificial substitution of rare and precious wild Chinese medicinal materials.

Hongjitang Pharmaceutical (Shanghe) Plant Updating Project Supposed To Be Completed At The End of 2024 (10)sfn

This breakthrough saved a group of national treasures, Chinese patent medicines that were difficult to formulate due to the scarcity of natural musk.

Hongjitang Pharmaceutical (Shanghe) Plant Updating Project Supposed To Be Completed At The End of 2024 (3)5jy

Currently, the Hongjitang Pharmaceutical Shanghe Project is in the midst of intense construction. Once completed, the project is expected to achieve an annual output value of 1.3 billion yuan. It aims to realize automation, digitization, and intelligence, constructing a park for the 5G+ industrial internet and green ecological fine chemical industry.